EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 entry found
1
Journal article icon
Journal article

Evaluation of Antitumor Activity Using Change in Tumor Size of the Survivin Antisense Oligonucleotide LY2181308 in Combination with Docetaxel for Second-Line Treatment of Patients with Non–Small-Cell Lung Cancer: A Randomized Open-Label Phase II Study

  • Natale, R, Blackhall, F, Kowalski, D, et al.
  • 2014-11-01
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP